10.1016/j.ejps.2021.105743 168 MohantyC.DasM.SahooS
Email 1 Dosing and self-administration instructions
Questions and Answers on Dietary Supplements
The FDAs biosimilar pathway, established under the BPCIA, requires extensive analytical characterization, animal studies, human pharmacokinetic and pharmacodynamic data, and in some cases clinical efficacy trials to demonstrate biosimilarity
Collectively, MOTS-c helps combat metabolic stress from high fat intake by activating AMPK, reducing lipids in tissues, and fine-tuning gene expression to favor a healthier metabolic profile
Clinical trials and real-world data show that gastrointestinal side effectsincluding nausea, vomiting, and refluxoccur in a meaningful proportion of GLP-1 users